Amondys 45 (Casimersen) Approval with Aetna (CVS Health) in New Jersey: Complete Guide to Prior Authorization, Appeals, and Coverage Requirements
Quick Answer: Getting Amondys 45 (Casimersen) Covered by Aetna (CVS Health) in New Jersey
Eligibility: DMD patients with exon 45-amenable mutations, under 14 at treatment start, able to walk ≥300 meters independently, prescribed by a neuromuscular specialist. Fastest path: Submit complete prior authorization with genetic test report, 6-minute walk test